DGAP-News: Raptor Pharmaceutical Corp. to Present at the 30th Annual JP Morgan Healthcare Conference
Raptor Pharmaceutical Corp.
04.01.2012 22:39
—————————————————————————
Raptor Hosts Open Event to Discuss NASH Program and Upcoming Phase 2b Clinical
Trial
NOVATO, Calif., 2012-01-04 22:39 CET (GLOBE NEWSWIRE) —
Raptor Pharmaceutical Corp. (–Raptor– or the –Company–) (Nasdaq:RPTP) today
announced that Christopher M. Starr, Ph.D., Raptor–s Chief Executive Officer,
will present an overview of the Company at the 30th Annual JP Morgan Heal
